Free Trial

Bio-Rad Laboratories (NYSE:BIO.B) Shares Cross Below Two Hundred Day Moving Average - Here's What Happened

Bio-Rad Laboratories logo with Medical background
Remove Ads

Bio-Rad Laboratories, Inc. (NYSE:BIO.B - Get Free Report) shares passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $324.63 and traded as low as $265.82. Bio-Rad Laboratories shares last traded at $265.82, with a volume of 11 shares trading hands.

Bio-Rad Laboratories Stock Performance

The business's fifty day moving average price is $304.61 and its 200-day moving average price is $323.57. The stock has a market cap of $6.78 billion, a PE ratio of -3.72 and a beta of 0.75. The company has a debt-to-equity ratio of 0.18, a quick ratio of 4.85 and a current ratio of 6.48.

Bio-Rad Laboratories (NYSE:BIO.B - Get Free Report) last released its quarterly earnings results on Thursday, February 13th. The company reported $2.90 earnings per share (EPS) for the quarter. Bio-Rad Laboratories had a positive return on equity of 3.90% and a negative net margin of 71.86%.

Bio-Rad Laboratories Company Profile

(Get Free Report)

Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.

Read More

Should You Invest $1,000 in Bio-Rad Laboratories Right Now?

Before you consider Bio-Rad Laboratories, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bio-Rad Laboratories wasn't on the list.

While Bio-Rad Laboratories currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

5 Stocks to BUY Now as Tariff Uncertainty Fades
WWE Stock Could Explode Next Week — Now’s the Time to Buy Into TKO
These 3 Dividend Stocks Might Be the Safest Bet Right Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads